Company Filing History:
Years Active: 2024
Title: Juan Carlos Gallar Ruiz: Innovator in Cancer Treatment
Introduction
Juan Carlos Gallar Ruiz is a notable inventor based in Torres de Cotillas, Spain. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic antibodies.
Latest Patents
Juan Carlos holds a patent for an "Anti-presenilin antibody for use in the prevention and/or treatment of cancer." This patent describes an antibody or fragment that targets presenilin, specifically the luminal loop of presenilin, to treat cancer. The invention involves administering a therapeutically effective quantity of the antibody or a pharmaceutical composition to individuals suffering from cancer. He has 1 patent to his name.
Career Highlights
Throughout his career, Juan Carlos has worked with various organizations, including Alzheimur 2012 S.L. and Fundación Universitaria San Antonio. His work has focused on developing innovative solutions to combat cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Juan Carlos has collaborated with notable colleagues such as Rogelio Gonzalez Sarmiento and Miguel Rodriguez Manotas. These partnerships have contributed to his research and the advancement of his patented technologies.
Conclusion
Juan Carlos Gallar Ruiz is a prominent figure in the field of cancer research, with a focus on innovative antibody therapies. His contributions through his patent and collaborations highlight his commitment to advancing medical science and improving treatment options for cancer patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.